United States · FDA National Drug Code directory
Sitagliptin and Metformin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-2036_8898638c-e4b3-4fdf-91e6-d39156e5ace9
- Product NDC
- 70710-2036
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- sitagliptin and metformin hydrochloride
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20241031
- Source listing expiry
- 20261231
Source-listed ingredients
- SITAGLIPTIN — 50 mg/1
- METFORMIN HYDROCHLORIDE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70710-2036-6) · 70710-2036-6
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →